StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$20.75M. The highest annual figure on record is -$19.97M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$20.75M–
FY2024Dec 31, 2024-$29.22M–
FY2023Dec 31, 2023-$19.97M–
FY2022Dec 31, 2022-$21.09M–
FY2021Dec 31, 2021-$26.84M–
FY2020Dec 31, 2020-$25.89M–

More CASI Pharmaceuticals figures

See a number that looks wrong?